1
0
0
News
Industry veteran appointed as Chief Scientific Officer of ...Oxford University Innovation
innovation.ox.ac.uk
— Georg C. Terstappen has been appointed to the role of Chief Scientific Officer (CSO) of spinout OxStem Ltd. With 25 years' experience in ...
Cambrian BioPharma Unveils New Pipeline CompanyABC27
www.abc27.com
— ... Georg C. Terstappen, PhD. "Using this state-of-the-art approach to drug discovery combined with an impressive team gives us great confidence ...
Cambrian BioPharma Unveils New Pipeline CompanyCBS 42
www.cbs42.com
— ... Georg C. Terstappen, PhD. "Using this state-of-the-art approach to drug discovery combined with an impressive team gives us great confidence ...
Cambrian BioPharma Unveils New Pipeline CompanyIsterian Biotech
www.isterian.com
— ... Georg C. Terstappen, PhD. “Using this state-of-the-art approach to drug discovery combined with an impressive team gives us great confidence ...
Netzwerk-Profile
LinkedIn: Georg C. Terstappen, PhD – Member of the Scientific ...
Georg C. Terstappen - a biologist by training with a PhD in natural sciences - has more than 30 years of experience in pharma R&D. Georg C. Terstappen - a biologist by training with a PhD in natural sciences - has more than 30 years of experience in pharma R&D.
LinkedIn: Georg C. Terstappen | LinkedIn
Sehen Sie sich das berufliche Profil von Georg C. Terstappen (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das ...
LinkedIn: Georg C. Terstappen | LinkedIn
Georg C. Terstappens berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Georg C. Terstappen ...
Es fehlt: geilenkirchen
LinkedIn: Georg C. Terstappen | Berufsprofil
Sehen Sie sich das Profil von Georg C. Terstappen auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. Georg C. Terstappen hat 13 Jobs im Profil angegeben. Sehen Sie sich auf LinkedIn das vollständige Profil an und erfahren Sie mehr über die Kontakte von Georg C. Terstappen und über Jobs bei ähnlichen ...
Interessen
Cambrian BioPharma Unveils New Pipeline CompanyPR Newswire
www.prnewswire.com
— ... Georg C. Terstappen, PhD. "Using this state-of-the-art approach to drug discovery combined with an impressive team gives us great confidence ...
A Multi-Site Omics StudyCell Press
www.cell.com
Peeters, Georg C. Terstappen, Martin Graf, Frederick J. Livesey, Colin J. Akerman, Kevin Mills, Rory Bowden, George Nicholson, Caleb Webber, M. Zameel Cader ...
In silico research in drug discoveryCell Press
www.cell.com
Georg C. Terstappen, Angelo Reggiani. Trends in Pharmacological Sciences. Volume 22 Issue 1 Pages (January 2001). DOI: S (00) Fig ...
Business-Profile
Biographie von Georg Terstappen - The Official Board
www.theofficialboard.de
Georg Terstappen ist derzeit Executive Vice President, Drug Discovery bei Cambrian Biopharma. Bei Cambrian Biopharma hat Georg Terstappen 40 Kollegen einschließlich James Peyer …
patentbuddy: Georg Terstappen
BAYER AKTIENGESELLSCHAFT, Dusseldorf, DE
Firmen-Mitarbeiter
BIOSCIE REPORTBiochemical Society
www.biochemistry.org
Georg C. Terstappen (OxStem, UK). Mark D. Turner (Nottingham Trent University,. UK). Rietie Venter (University of South Australia,. Australia). Qiong Annabel ...
NEUWAY Pharma GmbHAcademicLabs
app.academiclabs.com
Leadership. Chief Science Officer. Georg C. Terstappen. Georg is the Executive Vice President of Drug Discovery at Cambrian Biopharma. He has nearly 30 years ...
Scientific Advisory BoardNeuway Pharma
www.neuway-pharma.com
Georg C. Terstappen, Ph. D Chairman of the board Georg is the Executive Vice President of Drug Discovery at Cambrian Biopharma. Georg C. Terstappen, Ph. D Chairman of the board Georg is the Executive Vice President of Drug Discovery at Cambrian Biopharma.
TeamNugerontix Limited
www.nugerontix.com
Kevin Bilyard, PhD. Co-Founder. Read full bio · Co-Founder ; Roger Corder, PhD. Founder & CEO. Read full bio · Founder & CEO ; Georg C. Terstappen, PhD. Board ...
Bücher
In silico research in drug discovery. - DialnetDialnet
dialnet.unirioja.es
Georg C. Terstappen, Angelo Reggiani; Localización: Trends in pharmacological sciences, ISSN , Vol. 22, Nº 1, 2001, pág. 23; Idioma: inglés; Texto ...
Search Results for RSC PublishingRSC Publishing
pubs.rsc.org
You searched for: Keywords: Author:Georg C. Terstappen. Articles. Sort search results by. Relevance, Latest, Oldest. Search filters.
heiBIB: Draguhn, Andreas
katalog.ub.uni-heidelberg.de
... Andreas Draguhn, Georg C. Terstappen, Gerhard Gross, Hans Schoemaker, Gail Freiberg, Steve Pratt, Sujatha M. Gopalakrishnan and Volker Nimmrich.
bokus.com: Label-Free Technologies For Drug Discovery - Matthew Cooper, Lorenz M...
Köp Label-Free Technologies For Drug Discovery av Matthew Cooper, Lorenz M Mayr. Skickas inom vardagar. Fri frakt över 199 kr. Välkommen till Bokus...
Dokumente zum Namen
Dialysis Cell for Rapid Quantitative Analytical Determination of ...ACS Publications
pubs.acs.org
von PB HAMILTON · · Zitiert von: 40 — ... Georg C. Terstappen, Holger Fischer, Li Di, Nicola Colclough, Scott Summerfield, Stephen T. Buckley, Tristan S. Maurer, Markus Fridén. Unbound Brain-to ...
How to Achieve Confidence in Drug Discovery and ...Chemistry Europe
chemistry-europe.onlinelibrary.wiley.com
von A Bakker · · Zitiert von: 9 — Annette Bakker Dr Andrea Caricasole Dr Giovanni Gaviraghi Dr Giuseppe Pollio Dr Graeme Robertson Dr Georg C. Terstappen Dr. von A Bakker · · Zitiert von: 9 — Annette Bakker Dr Andrea Caricasole Dr Giovanni Gaviraghi Dr Giuseppe Pollio Dr Graeme Robertson Dr Georg C. Terstappen Dr.
IMB Career Day 4 July, 2014
www.imb.de
Dr Georg Terstappen . Director and Head of Biology, Neuroscience Discovery AbbVie Deutschland . 14: :15 ; Dr Ruth Wagner . Line Manager High-Throughput Screening bei …
KEYSTONE SYMPOSIA - IBBS
www.ibbsoc.org
Georg Terstappen, Cambrian Biopharma, USA Drug Delivery to the Brain: History, Strategies, Needs, & Opportunities CNS Barriers: Categorization and Essential Physiological …
Wissenschaftliche Veröffentlichungen
In silico research in drug discoveryScienceDirect.com
www.sciencedirect.com
von GC Terstappen · · Zitiert von: 494 — Review. In silico research in drug discovery. Author links open overlay panel. Georg C. Terstappen a , Angelo Reggiani a. Show more. Add to Mendeley. Share.
Huntington's disease: from experimental results to interaction ...BMC Systems Biology
bmcsystbiol.biomedcentral.com
von E Gonzalez-Couto · · Zitiert von: 4 — Eduardo Gonzalez-Couto · Silvia Matteoni · Stefano Gotta · Letizia Magnoni · Freddy Heitz · Roberto Raggiaschi · Georg C Terstappen · Andreas Kremer.
Roberto RaggiaschiDBLP
dblp.org
— Georg C. Terstappen, Andreas Kremer: Huntington's disease: from experimental results to interaction networks, patho-pathway construction and ...
Drug Discovery Today | Vol 27, Issue 11, November 2022ScienceDirect.com
www.sciencedirect.com
— ... Georg C. Terstappen, Yipeng Wang. Article : View PDF. Article preview. select article Digital biomarkers for post-licensure safety ...
Veröffentlichungen allgemein
Editorial Note | Bioscience ReportsSpringer
link.springer.com
Georg C. Terstappen. Authors. Georg C. Terstappen. View author publications. You can also search for this author in PubMed Google Scholar. Rights and ...
Überwindung der Blut-Hirn-Schranke bei Alzheimer und ...Presseportal
www.presseportal.de
— Georg C. Terstappen, Leiter der biologischen Forschung bei AbbVie Deutschland in Ludwigshafen. Der Einsatz von biologischen Wirkstoffen war ...
Phosphoproteome Analysis | Bioscience ReportsSpringer
link.springer.com
von R Raggiaschi · · Zitiert von: 103 — Georg C. Terstappen. 65 Accesses. 50 Citations. 9 Altmetric. 1 Mention. Explore all ... Roberto Raggiaschi, Stefano Gotta & Georg C. Terstappen. Authors. Roberto ...
Nonradioactive Rubidium Ion Efflux Assay and Its ...Aurora Biomed
www.aurorabiomed.com
von GC Terstappen · · Zitiert von: 35 — Georg C. Terstappen. Discovery Research. Sienabiotech S.p.A.. Via Fiorentina Siena. Italy. . Nonradioactive Rb. +.
Artikel & Meinungen
My journey — developing therapies to extend healthspanCambrian Bio
www.cambrianbio.com
Copied! My journey — developing therapies to extend healthspan. 6 mins to read. May 9, Author: Georg C. Terstappen, PhD. I work in the ...
Twitter-Nachrichten: Cambrian on Twitter: "What motivated Georg C. Terstappen, PhD to ...twitter.com › cambrianbio › status
— What motivated Georg C. Terstappen, PhD to join Cambrian as EVP of Drug Discovery? Cambrian's vibrant team working to lengthen healthspan ...
Target deconvolution strategies in drug discovery | Nature Reviews...
www.nature.com
Georg C. Terstappen, Christina Schlüpen, Roberto Raggiaschi & Giovanni Gaviraghi. Nature Reviews Drug Discovery 6, (November 2007).
| Nature Careers
www.nature.com
Mark Day, Global Lead, CNS Search and Evaluation Georg Terstappen, Director and Head of Biology – Neuroscience Discovery, AbbVie
Sonstiges
Georg Terstappen Präzisionsformenbau, Brüggen | Firmenauskunft
firmeneintrag.creditreform.de
Georg Terstappen Präzisionsformenbau mit Sitz in Brüggen ist in der Creditreform Firmendatenbank mit der Rechtsform Gewerbebetrieb eingetragen. Das Unternehmen ist …
Georg Terstappen in Brüggen - Allgemeine SEO Auskunft
allgemeine-seoauskunft.com
Georg Terstappen, auf Allgemeine SEO Auskunft ist Dein Ansprechpartner in der Nähe, für den Bereich Schlossereien in Brüggen. Das Unternehmen hat seinen Sitz in , Brüggen, …
Georg Christian Terstappen aus Neckarhausen - Manager-Profil
www.companyhouse.de
Werdegang von Georg Christian Terstappen aus Neckarhausen: früher Prokurist der Abbott GmbH & Co, früher Prokurist der AbbVie Deutschland GmbH & Co. KG
(PDF) In silico research in drug discovery. (2000)AI Chat for scientific PDFs | SciSpace
typeset.io
Georg C. Terstappen Nov Assay and Drug Development Technologies. Show Less. TL;DR: These methods will briefly describe fluorescence-based methods ...
A Continuous Time-Resolved Fluorescence Assay for ...Mary Ann Liebert, Inc.
www.liebertpub.com
von V Porcari · · Zitiert von: 23 — A Continuous Time-Resolved Fluorescence Assay for Identification of BACE1 Inhibitors. Valentina Porcari,; Letizia Magnoni,; Georg C. Terstappen, and; Wolfgang ...
A Primer on Screening Data ManagementSLAS Discovery
www.slas-discovery.org
von M Palmer · · Zitiert von: 1 — Georg C. Terstappen. Georg C. Terstappen. Affiliations. Siena Biotech S.p.A., Siena, Italy. Search for articles by this author. Open AccessDOI:https://doi.org ...
A call for better understanding of target engagement in Tau ...Helsinki.fi
researchportal.helsinki.fi
von A Bespalov · · Zitiert von: 7 — A call for better understanding of target engagement in Tau antibody development. Anton Bespalov, Jean-Philippe Courade, Leonard Khiroug, Georg C. Terstappen, ...
ASSAY and Drug Development Technologies | Vol 2, No 5Mary Ann Liebert, Inc.
www.liebertpub.com
Nonradioactive Rubidium Ion Efflux Assay and Its Applications in Drug Discovery and Development · Dr. Georg C. Terstappen. Pages:553–559; Published Online:
The Neuro4D Conference
www.neuro4d.com
Novel Technology Section, chaired by Georg Terstappen. Overview of AD Clinical Trials, by Oliver Peters. Discussion of the most recent discoveries in neurodegenerative diseases. New …
Andreas Kremer | Scholar Profiles and RankingsScholarGPS
scholargps.com
Georg C. Terstappen (3). Letizia Magnoni (2). Roberto Raggiaschi (2). Stefano Gotta (2). Claus A. Andersen (1). Eduardo Gonzalez-Couto (1). Freddy Heitz (1).
BlogsCambrian Bio
www.cambrianbio.com
My journey — developing therapies to extend healthspan. Our former EVP of Drug Discovery, Georg C. Terstappen, shares how his passion drove him to embark on ...
Cambrian BioThe Healthcare Technology Report.
thehealthcaretechnologyreport.com
She effectively manages all aspects of the clinical development process at Cambrian. Georg C. Terstappen, PhD., EVP, Drug Discovery. Georg joined Cambrian in ...
Cambrian Biopharma CEO and Key Executive Team - Craft.cocraft.co
craft.co
James Peyer · Juliette Han · Mark Nuttall · Georg C. Terstappen · Dennis Yamashita · Teri Champ · Christian Angermayer · Maryanna Saenko.
Career – BioMed X InstituteBioMed X Institute
bio.mx
This video was kindly provided by AbbVie (special thanks to Georg C. Terstappen). External content blocked. External content from youtube-nocookie.com was ...
Detailled Reference - ORBiluORBilu
orbilu.uni.lu
von A Kremer · · Zitiert von: 37 — Crossref | Publisher: 'Springer Science and Business Media LLC'. by Andreas Kremer, Reinhard Schneider, Georg C. Terstappen, R. Apweiler, G. D. Bader, M ...
Development and Validation of a Fluorescence-Based HTS ...Bentham Science Publisher
benthamscience.com
Swensen, Andreas Draguhn, Georg C. Terstappen, Gerhard Gross, Hans Schoemaker, Gail Freiberg, Steve Pratt, Sujatha M. Gopalakrishnan and Volker Nimmrich. 65,00 $
Evolving approaches on measurements and applications ...OUCI
ouci.dntb.gov.ua
... Georg C. Terstappen, Holger Fischer, Li Di, Nicola Colclough, Scott Summerfield, Stephen T. Buckley, Tristan S. Maurer, Markus Fridén. https://doi.org ...
Figure 1 from In silico research in drug discovery.Semantic Scholar
www.semanticscholar.org
Georg C. Terstappen, Angelo Reggiani · Published in TIPS - Trends in… · Chemistry, Computer Science, Medicine.
High Throughput Scintillation Proximity Assay for the ...SLAS Discovery
www.slas-discovery.org
von F Graziani · · Zitiert von: 31 — GlaxoWellcome Medicines Research Centre, Department of Lead Discovery, Verona, Italy. Search for articles by this author. Georg C. Terstappen. Georg C.
Ion channel screening technologies today - Sophion Biosciencesophion.co.jp
sophion.co.jp
Go to journal 著者: Georg C. Terstappen. For every heartbeat, movement and thought, ion channels have to open and close, and thus, it is not surprising that ...
Verwandte Suchanfragen zu Georg C. Terstappen
|
Personen Vorname "Georg" (36045) Name "Terstappen" (77) |
sortiert nach Relevanz / Datum